Established In March 2016Coherent Biopharmasuzhouco Ltd Icbpi Is Committed To Theresearchdevelopment And Industrialization Of Tumor Targeting Ligand Conjugatedrugs And Tumor Biomarker Diagnostic Reagents Rich Experiencein New Drug Research And Development Management At Homeand Abroadthecompany S Management Team Is Composed Of Several Outstanding Biological R&Dmedicinal Chemistry Cmcpreclinicaland Clinical Expertsincluding Two Experts Awarded With National Key Talent Introduction Projectoneexpert With Thetitleof Jiangsu Provincial Innovation High Level Talentsall Members Of Themanagement Team Haveextensiveexperiencein Major Domestic And Overseas Drug Companiescbp Has Developed A Widerangeof Product Pipelines Based On Its Own Bi Engaging Ligand Mediated Selectivetargeting Platformbesttm Thefirst Productcbp 1008Has Obtained China S Clinical Approval And Us Fda S Clinical Trial Approvaland Phasei Clinical Study Is On Goingthesecond Product Cbp 1018Has Obtained Thenmpa Clinical Trial Approval From Nmpa Recentlyseveral Other New Drug Candidates Areat Various Stages Of Product Developmentthey Will Enter Clinical Phasein Thenext Few Years
